T lymphocytes play a central role in cellular and humoral immune responses, carrying out direct effector functions such as cytolysis as well as mediating regulatory functions via secreted lymphokines. While the TCR accounts for the specificity of T cell responses, other T cell surface molecules also influence T cell responses. Some T cell surface structures correlate with the class of MHC antigen which restricts their responses: CD8+ """"""""cytolytic"""""""" T cells are restricted by class I MHC antigens while CD4+ 'helper' T cells are restricted by class II MHC antigens. CD4+ T cells have been subdivided further on the basis of the array of secreted lymphokines: T(H)1 cells secrete IL-2 and IFN-gamma but not IL-4 or IL-5 while T(H)2 cells secrete IL-4 and IL-5 but not IL-2 or IFN-gamma. This distinction also correlates with functional differences between these subsets: T(H)l calls mediate delayed-type hypersensitivity while T(H)2 cells efficiently 'help' B cells responses. These CD4+ T cell subsets also respond differently to immunoregulatory processes: IFN-gamma inhibits the proliferation of T(H)2 clones, but not of T(H)l clones. T(H)1 cells pretreated with IL-2 do not respond when stimulated subsequently through the TCR; proliferation of T(H)2 cells is enhanced by IL-2 pre--treatment. Treatment of T(H)l clones with high concentrations of anti-TCR mAb inhibits IL-2-induced proliferation; this treatment augments proliferation of T(H)2 clones. Signalling pathways also differ; stimulation of the TCR induces an increase in intracellular (Ca2+) in T(H)l but not in T(H)2 clones. The general goal of this research proposal is to characterize further some of the regulatory processes that control differentially the functions of murine CD4+ T lymphocyte subsets. There are four Specific Aims: 1) To determine the biochemical basis for the differences in signal transduction observed in murine T(H)1 and T(H)2 clones; 2) To determine the basis for the selective stimulation of proliferation of T(H)l cells by splenic adherent cells (AC) and of T(H)2 cells by B cells; 3) To identify other possible selective influences that favor activation and expansion of T(H)1, T(H)2, and other murine T cell subsets; and 4) To develop mAb which can distinguish between murine T(H)l and T(H)2 T call subsets. The proposed studies should provide insights into the regulatory processes that control T cell growth and function.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA019266-15
Application #
3793628
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Hekmatpanah, Javad (2007) Cerebral microvessel perfusion and pathologic alteration of the brain during drowsiness and coma caused by brain tumor: a laboratory study on rats. Surg Neurol 67:564-71;discussion 571
Wiesner, D A; Kilkus, J P; Gottschalk, A R et al. (1997) Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL. J Biol Chem 272:9868-76
Bergmann, B M; Rechtschaffen, A; Gilliland, M A et al. (1996) Effect of extended sleep deprivation on tumor growth in rats. Am J Physiol 271:R1460-4
Van Waes, C; Monach, P A; Urban, J L et al. (1996) Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro. Tissue Antigens 47:399-407
Cronin 2nd, D C; Stack, R; Fitch, F W (1995) IL-4-producing CD8+ T cell clones can provide B cell help. J Immunol 154:3118-27
Gottschalk, A R; McShan, C L; Kilkus, J et al. (1995) Resistance to anti-IgM-induced apoptosis in a WEHI-231 subline is due to insufficient production of ceramide. Eur J Immunol 25:1032-8
Pekarek, L A; Starr, B A; Toledano, A Y et al. (1995) Inhibition of tumor growth by elimination of granulocytes. J Exp Med 181:435-40
Monach, P A; Meredith, S C; Siegel, C T et al. (1995) A unique tumor antigen produced by a single amino acid substitution. Immunity 2:45-59
Seung, L P; Seung, S K; Schreiber, H (1995) Antigenic cancer cells that escape immune destruction are stimulated by host cells. Cancer Res 55:5094-100
Lancki, D W; Qian, D; Fields, P et al. (1995) Differential requirement for protein tyrosine kinase Fyn in the functional activation of antigen-specific T lymphocyte clones through the TCR or Thy-1. J Immunol 154:4363-70

Showing the most recent 10 out of 104 publications